Diabetes business in Japan Comprehensive support for diabetes patients’ happier lives
There are two types of diabetes: Type I, in which a patient's body has difficulty producing insulin; and Type II, which often occurs as a result of people’s lifestyles. It is vital to society that diabetes is discovered early and that its possible complications prevented. Diabetic patient ages range widely, from children to the elderly. Many patients measure and manage their own blood glucose daily, and some also perform their own injections to regulate their blood glucose levels.
Diabetes treatment imposes great stress on a patient’s mind and body due to various restrictions and difficulties in daily life, such as dietary constraints, as well as the measurement and management of blood glucose. Terumo offer a range of products in Japan, such as a detachable insulin pump, continuous glucose monitoring systems that allow constant monitoring of glucose concentration changes in real time, an easy-to-use continuous glucose monitoring system, and the world’s thinnest double tapered pen needle.*
This full product lineup provides comprehensive daily support for diabetes patients and contributes to a better quality of life for them.
*Based on research by Terumo Corporation in November 2020.
Terumo is a market leader in the Japanese diabetes field.
In addition to high-quality products with a patient-centric design, customer support for devices is also reliably provided. This is highly acclaimed by diabetes patients and medical specialists.
Note: The regulatory approval status and availability of these products differ by country and region.
Responding to the needs of various medical fields, Terumo provides a wide range of solutions that contribute to “ensuring treatment safety," “improving work efficiency," and “enhancing patients’ quality of life.”
Manufacturing Advanced production technologies and systems realizing a fast, stable supply of high-quality products
As a leading medical device company, Terumo is continually strengthening its global efforts to stably deliver high-quality products to the world. Particularly in facilities with product development functions located mainly in Japan, technicians in such departments as Development, Production Technology, and Production work closely together from the earliest stages of product development. Following this, thorough the optimization of the supply chain from material procurement to design, production and delivery to medical sites is promoted. Under the direction of the CMO (Chief Manufacturing Officer), the entire group effectively utilizes the unique strengths of each factory and the manufacturing capabilities that have been refined for each business.
There were 14 Terumo production facilities worldwide until the 1990s, but this number has more than doubled over the last 20 years. Currently, there are more than 30 manufacturing locations for the entire group. Each of these belongs to either the Cardiovascular Company, General Hospital Company, or Blood and Cell Technologies Company and realizes stable, precision production enabled by Terumo’s advanced technologies and stringent quality control. High-quality mass production is also available utilizing image inspection systems with AI.*
*Please contact us
